Venture capitalists invested $3.5 billion in 406 deals within the biotech sector, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Association. The industry experienced a 19% drop in investments last year but outperformed other sectors, grabbing the largest share of venture capital funds, the report noted.

Related Summaries